Lobbying Filing Details

Total Spending

$250,000

Activities

2

Lobbyists

1

Gov't Entities

2

Filing Information
Filing UUID:
25cb76c6-3f73-4a82-94f4-4ee38c0203bc
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2026 at 5:32 PM
Income:
$250,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: David Friedman
Registrant
DAVID FRIEDMAN
Coral Gables, Florida
Client
TEVA PHARMACEUTICALS USA, INC.

Pharmaceutical manufacturer.

New Jersey, United States of America
Lobbying Activities (2)
Activity 1
Manufacturing

Issues related to strengthening the domestic supply and manufacture of essential medicines.

Foreign Entity Issues: Teva Pharmaceutical Industries Ltd., identified on Registration (LD-1) as the parent company, would benefit from similar opportunities as identified in this report related to the domestic manufacturing of essential medicines.

Lobbyists (1)
  • DAVID FRIEDMAN
Government Entities (1)
  • Commerce, Dept of (DOC)
Activity 2
Pharmacy

Issues related to strengthening the domestic supply and manufacture of essential medicines.

Foreign Entity Issues: Teva Pharmaceutical Industries Ltd., identified on Registration (LD-1) as the parent company, would benefit from similar opportunities as identified in this report related to the domestic manufacturing of essential medicines.

Lobbyists (1)
  • DAVID FRIEDMAN
Government Entities (1)
  • Commerce, Dept of (DOC)

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.